Triaziquone

Triaziquone

SCHEMBL635992

O=C1C=C(N2CC2)C(=O)C(N2CC2)=C1N1CC1.O=P([O-])(O)O.[Na+]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Triaziquone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 1/20 0.39
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
STAT3 P40763 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
APAF1 O14727 2/20 0.33
TDP2 O95551 2/20 0.33
NSD2 O96028 2/20 0.33
HKDC1 Q2TB90 2/20 0.33
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
HIF1A Q16665 1/20 0.31
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
GALK1 P51570 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triaziquone SCHEMBL62271 0.91 DNMT1 (0.42) DNMT1TP53MAPTSTAT3HTT
Triaziquone SCHEMBL3903553 0.91 DNMT1 (0.42) DNMT1TP53MAPTSTAT3HTT
Triaziquone SCHEMBL10680234 0.89 DNMT1 (0.41) DNMT1TP53MAPTSTAT3HTT
Triaziquone SCHEMBL9218251 0.88 DNMT1 (0.38) DNMT1TP53MAPTSTAT3HTT
Triaziquone SCHEMBL21805756 0.88 MAPT (0.39) DNMT1TP53MAPTSTAT3HTT
Triaziquone SCHEMBL9218892 0.88 DNMT1 (0.33) DNMT1TP53MAPTSTAT3HTT
Triaziquone SCHEMBL20515128 0.88 DNMT1 (0.40) DNMT1TP53MAPTSTAT3HTT
Triaziquone SCHEMBL21625776 0.88 MAPT (0.41) DNMT1TP53MAPTSTAT3HTT
Triaziquone SCHEMBL7064057 0.88 DNMT1 (0.40) DNMT1TP53MAPTSTAT3HTT
Triaziquone SCHEMBL9678206 0.86 DNMT1 (0.39) DNMT1TP53MAPTSTAT3HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4259447-A ADSORPTION BY APROTININ COVALENTLY BOUND TO POROUS MATRIX ALPHA PATENT LIMITED (IL) 1981-03-31 US claimed
WO-2024026446-A1 METHOD FOR PURIFYING A POLYPEPTIDE COMPRISING TWO IMAC STEPS AND APPARATUS THEREFORE GENENTECH, INC. (US) 2024-02-01 WO disclosed
EP-2071022-B1 S-ADENOSYLMETHIONINE SYNTHETASE MUTANTS, THE DNAS ENCODING THE SAME AND USES OF THE MUTANTS BIORIGHT WORLDWIDE CO LTD (VG) 2012-02-22 EP disclosed
US-7858351-B2 S-adenosylmethionine synthetase mutants, the DNAs encoding the same and uses of the mutants GENEHARBOR ( HONG KONG) TECHNOLOGIES, LTD. (CN) 2010-12-28 US disclosed
US-20090203080-A1 S-Adenosylmethionine Synthetase Mutants, the DNAs Encoding the Same and Uses of the Mutants GENEHARBOR (HONG KONG) TECHNOLOGIES LTD. (CN) 2009-08-13 US disclosed
EP-2071022-A1 S-ADENOSYLMETHIONINE SYNTHETASE MUTANTS, THE DNAS ENCODING THE SAME AND USES OF THE MUTANTS Bioright Worldwide Company Limited (VG) 2009-06-17 EP disclosed